• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎对弥漫性大B细胞淋巴瘤的因果效应:一项两样本孟德尔随机化研究。

Causal effect of primary sclerosing cholangitis on diffuse large B-cell lymphoma: A two-sample Mendelian randomized study.

作者信息

Miao Zhengyang, Chen Hailin, Zhou Yongming

机构信息

Department of Hematology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Medicine (Baltimore). 2024 Nov 22;103(47):e40542. doi: 10.1097/MD.0000000000040542.

DOI:10.1097/MD.0000000000040542
PMID:39809190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11596531/
Abstract

The connection between Primary sclerosing cholangitis (PSC) and lymphoma remains uncertain. To address this, Mendelian randomization (MR) was utilized to investigate the potential causal links between PSC and lymphoma. A 2-sample MR analysis was conducted utilizing summary-level data obtained from genome-wide association study datasets. Four complementary MR methods were performed, including inverse-variance weighting (IVW), MR-Egger, weighted median, and MR-robust adjusted profile score (MR-RAPS). Several sensitivity analyses were also employed to further validate the results. The results of IVW estimates showed that there was a potential causal association between PSC and diffuse large B-cell lymphoma (DLBCL) risk (OR = 1.138, 95% CI = 1.052-1.230, P = .001). No causal association was observed between PSC and other lymphoma subtypes. No horizontal and directional pleiotropy was observed in the MR studies. This study represents the inaugural utilization of MR analysis to investigate the causal associations between PSC and DLBCL. Further investigation is warranted to elucidate the underlying mechanism of this causal relationship.

摘要

原发性硬化性胆管炎(PSC)与淋巴瘤之间的联系仍不明确。为解决这一问题,采用孟德尔随机化(MR)方法来研究PSC与淋巴瘤之间潜在的因果关系。利用从全基因组关联研究数据集获得的汇总水平数据进行了两样本MR分析。执行了四种互补的MR方法,包括逆方差加权(IVW)、MR-Egger、加权中位数和MR稳健调整轮廓评分(MR-RAPS)。还采用了几种敏感性分析来进一步验证结果。IVW估计结果显示,PSC与弥漫性大B细胞淋巴瘤(DLBCL)风险之间存在潜在因果关联(OR = 1.138,95%CI = 1.052 - 1.230,P = 0.001)。未观察到PSC与其他淋巴瘤亚型之间存在因果关联。在MR研究中未观察到水平和方向性多效性。本研究首次利用MR分析来研究PSC与DLBCL之间的因果关联。有必要进行进一步研究以阐明这种因果关系的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/2d7dc2f9d048/medi-103-e40542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/38f5784d27e0/medi-103-e40542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/73e577f0ce8f/medi-103-e40542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/9b0bd5095210/medi-103-e40542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/2d7dc2f9d048/medi-103-e40542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/38f5784d27e0/medi-103-e40542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/73e577f0ce8f/medi-103-e40542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/9b0bd5095210/medi-103-e40542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60b/11596531/2d7dc2f9d048/medi-103-e40542-g004.jpg

相似文献

1
Causal effect of primary sclerosing cholangitis on diffuse large B-cell lymphoma: A two-sample Mendelian randomized study.原发性硬化性胆管炎对弥漫性大B细胞淋巴瘤的因果效应:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2024 Nov 22;103(47):e40542. doi: 10.1097/MD.0000000000040542.
2
Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study.原发性硬化性胆管炎与甲状腺功能障碍的遗传关联:一项双向两样本孟德尔随机化研究。
Front Immunol. 2023 Oct 19;14:1276459. doi: 10.3389/fimmu.2023.1276459. eCollection 2023.
3
Dissecting the causal role of immunophenotypes in primary sclerosing cholangitis risk: A Mendelian randomization study.剖析免疫表型在原发性硬化性胆管炎风险中的因果作用:一项孟德尔随机化研究。
Medicine (Baltimore). 2024 Jun 28;103(26):e38626. doi: 10.1097/MD.0000000000038626.
4
Association between autoimmune liver diseases and chronic hepatitis B: A multivariable Mendelian randomization study in European population.自身免疫性肝病与慢性乙型肝炎的相关性:欧洲人群多变量孟德尔随机化研究。
Prev Med. 2024 Jul;184:107984. doi: 10.1016/j.ypmed.2024.107984. Epub 2024 May 3.
5
Primary sclerosing cholangitis causally affects kidney function decline: A Mendelian randomization study.原发性硬化性胆管炎可导致肾功能下降:一项孟德尔随机化研究。
J Gastroenterol Hepatol. 2024 Jan;39(1):185-192. doi: 10.1111/jgh.16355. Epub 2023 Sep 19.
6
Mendelian randomization analysis reveals causal effects of inflammatory bowel disease and autoimmune hyperthyroidism on diffuse large B-cell lymphoma risk.孟德尔随机化分析揭示了炎症性肠病和自身免疫性甲状腺功能亢进症对弥漫性大 B 细胞淋巴瘤风险的因果影响。
Sci Rep. 2024 Nov 25;14(1):29163. doi: 10.1038/s41598-024-79791-4.
7
The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study.基因预测的炎症性肠病对肠外表现的因果影响:一项孟德尔随机化研究。
BMC Gastroenterol. 2025 Mar 4;25(1):135. doi: 10.1186/s12876-024-03566-4.
8
Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study.原发性硬化性胆管炎与系统性红斑狼疮之间的因果关系:一项双向孟德尔随机化研究。
Eur J Med Res. 2024 Jun 28;29(1):351. doi: 10.1186/s40001-024-01941-1.
9
Causality of immune cells on primary sclerosing cholangitis: a bidirectional two-sample Mendelian randomization study.免疫细胞对原发性硬化性胆管炎的因果关系:一项双向两样本孟德尔随机化研究。
Front Immunol. 2024 Jul 1;15:1395513. doi: 10.3389/fimmu.2024.1395513. eCollection 2024.
10
Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study.原发性硬化性胆管炎与炎症性肠病之间共享遗传结构的研究:一项孟德尔随机化研究
BMC Gastroenterol. 2024 Feb 19;24(1):77. doi: 10.1186/s12876-024-03162-6.

本文引用的文献

1
Current Therapeutics in Primary Sclerosing Cholangitis.原发性硬化性胆管炎的当前治疗方法
J Clin Transl Hepatol. 2023 Oct 28;11(5):1267-1281. doi: 10.14218/JCTH.2022.00068S. Epub 2023 Apr 17.
2
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.原发性硬化性胆管炎 (PSC) 和炎症性肠病 (IBD):一种体现肠道-肝脏轴相互作用的病症。
Exp Mol Med. 2023 Jul;55(7):1380-1387. doi: 10.1038/s12276-023-01042-9. Epub 2023 Jul 18.
3
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.
抗原驱动的结肠炎症与原发性硬化性胆管炎中异型增生的发展有关。
Nat Med. 2023 Jun;29(6):1520-1529. doi: 10.1038/s41591-023-02372-x. Epub 2023 Jun 15.
4
Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study.炎症性肠病患者恶性淋巴瘤的风险:一项基于人群的队列研究。
BMJ Open Gastroenterol. 2023 May;10(1). doi: 10.1136/bmjgast-2022-001037.
5
The Immunology of DLBCL.弥漫性大B细胞淋巴瘤的免疫学
Cancers (Basel). 2023 Jan 29;15(3):835. doi: 10.3390/cancers15030835.
6
Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.探讨类风湿关节炎和弥漫性大 B 细胞淋巴瘤之间的分子机制和共同基因特征。
Front Immunol. 2022 Oct 31;13:1036239. doi: 10.3389/fimmu.2022.1036239. eCollection 2022.
7
Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers.具有多种异常免疫标志物的弥漫性大B细胞淋巴瘤的综合基因组和转录组分析
Front Oncol. 2022 Feb 14;12:790720. doi: 10.3389/fonc.2022.790720. eCollection 2022.
8
Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.基于人群的研究:自身免疫性疾病与淋巴瘤的关联:韩国国家健康保险服务-国家样本队列 2002-2015。
J Autoimmun. 2021 Jul;121:102647. doi: 10.1016/j.jaut.2021.102647. Epub 2021 May 12.
9
Diffuse Large B-Cell Lymphoma.弥漫性大 B 细胞淋巴瘤。
N Engl J Med. 2021 Mar 4;384(9):842-858. doi: 10.1056/NEJMra2027612.
10
Educational attainment impacts drinking behaviors and risk for alcohol dependence: results from a two-sample Mendelian randomization study with ~780,000 participants.教育程度影响饮酒行为和酒精依赖风险:一项约78万名参与者的两样本孟德尔随机化研究结果
Mol Psychiatry. 2021 Apr;26(4):1119-1132. doi: 10.1038/s41380-019-0535-9. Epub 2019 Oct 25.